// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Investigating the utility of subcutaneous implantable cardioverter-defibrillators in the adult congenital heart disease population

H R Garside - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Implementation of opportunistic screening at Pre-Assessment Clinics for upgrade/downgrade of cardiac devices

A Padwick - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Primary care based opportunistic screening for atrial fibrillation increases detection rates

F De Vere - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Early prolonged ambulatory cardiac monitoring in stroke (EPACS) – an open-label randomised controlled trial

AK Kaura - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Atrial arrhythmia detection by implantable loop recorder in patients with and without previous stroke; implications for investigating patients with unexplained ischaemic stroke

P A Chousou - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Assessment of cardiac arrhythmias at extreme high altitude using an implantable cardiac monitor: REVEAL HA Study

CJ Boos - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Remote monitoring of ILRs, when is more too much?

G Pounds - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SAFE2SCREEN - can patient initiated kiosk-based self-screening provide an opportunity to identify atrial fibrillation within a GP waiting room environment?

C Crockford - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Cied lead extraction in the elderly has low risk

A Zaidi - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

First evidence that differences in the t-wave upslope of the body surface ECG reflect right to left dispersion of repolarization in the intact human heart

NT Srinivasan - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical outcomes of cardiac resynchronization therapy with or without defibrillation in non-ischemic cardiomyopathy: impact of left ventricular midwall fibrosis

A. Zegard - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

A multi-centre UK clinical experience with wireless intracardiac left ventricular endocardial stimulation for delivery of cardiac resynchronisation therapy (WiSE CRT).

JM Behar - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Left atrial voltage predicts AF recurrence after ablation, irrespective of the rhythm during mapping, while circulating biomarkers of fibrosis do not.

G A Begg - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Refining the diagnostic criteria of the postural orthostatic tachycardia syndrome (POTS) using power spectral indices

A Sau - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Nitroglycerin

Thromboembolic events in left ventricular endocardial pacing: long-term outcomes from a Multicentre UK registry

V Sawhney - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Long-term outcomes of supraventricular tachycardia ablation in congenital heart disease: single centre UK experience

V Sawhney - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Neuro-cardiac profiling of electrophysiologic and structural remodeling in an in-vitro rabbit heart failure model

SH Chin - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Optimising the predictive capability of a mathematical model of AF progression using cardiac device data

E T Y Chang - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of the presence of left atrial low voltage areas on outcomes from pulmonary vein isolation

F Ahmed-Jushuf - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Effect of activation wavefront on electrogram characteristics during ventricular tachycardia ablation

CA Martin - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved